Evolving management of positive regional lymph nodes in melanoma: Past, present and future directions

被引:16
作者
Fayne, Rachel A. [1 ]
Macedo, Francisco, I [2 ]
Rodgers, Steven E. [1 ]
Moller, Mecker G. [1 ]
机构
[1] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Div Surg Oncol,Dewitt Daughtry Dept Surg, Coral Gables, FL 33136 USA
[2] Univ Cent Florida, Coll Med, North Florida Reg Med Ctr, Dept Surg, Miami, FL USA
关键词
Melanoma; sentinel lymph node biopsy; completion lymph node dissection; AMERICAN JOINT COMMITTEE; HIGH-DOSE INTERFERON-ALPHA-2B; HIGH-RISK MELANOMA; SENTINEL-NODE; COMPLETION LYMPHADENECTOMY; METASTATIC MELANOMA; ADJUVANT IRRADIATION; CUTANEOUS MELANOMA; CLINICAL-RELEVANCE; RADIATION-THERAPY;
D O I
10.4081/oncol.2019.433
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sentinel lymph node (SLN) biopsy has become the standard of care for lymph node staging in melanoma and the most important predictor of survival in clinically node-negative disease. Previous guidelines recommend completion lymph node dissection (CLND) in cases of positive SLN; however, the lymph nodes recovered during CLND are only positive in a minority of these cases. Recent evidence suggests that conservative management (i.e. observation) has similar outcomes compared to CLND. We sought to review the most current literature regarding the management of SLN in metastatic melanoma and to discuss potential future directions.
引用
收藏
页码:175 / 182
页数:8
相关论文
共 102 条
[1]   Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma [J].
Andtbacka, Robert H. I. ;
Kaufman, Howard L. ;
Collichio, Frances ;
Amatruda, Thomas ;
Senzer, Neil ;
Chesney, Jason ;
Delman, Keith A. ;
Spitler, Lynn E. ;
Puzanov, Igor ;
Agarwala, Sanjiv S. ;
Milhem, Mohammed ;
Cranmer, Lee ;
Curti, Brendan ;
Lewis, Karl ;
Ross, Merrick ;
Guthrie, Troy ;
Linette, Gerald P. ;
Daniels, Gregory A. ;
Harrington, Kevin ;
Middleton, Mark R. ;
Miller, Wilson H., Jr. ;
Zager, Jonathan S. ;
Ye, Yining ;
Yao, Bin ;
Li, Ai ;
Doleman, Susan ;
VanderWalde, Ari ;
Gansert, Jennifer ;
Coffin, Robert S. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (25) :2780-U98
[2]  
[Anonymous], CLIN PRACT GUID MAN
[3]   Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm) [J].
Balch, CM ;
Soong, SJ ;
Ross, MI ;
Urist, MM ;
Karakousis, CP ;
Temple, WJ ;
Mihm, MC ;
Barnhill, RL ;
Jewell, WR ;
Wanebo, HJ ;
Harrison, R .
ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (02) :87-97
[4]   Adjuvant irradiation for axillary metastases from malignant melanoma [J].
Ballo, MT ;
Strom, EA ;
Zagars, GK ;
Bedikian, AY ;
Prieto, VG ;
Mansfield, PF ;
Lee, JE ;
Gershenwald, JE ;
Ross, MI .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (04) :964-972
[5]   Adjuvant irradiation for cervical lymph node metastases from melanoma [J].
Ballo, MT ;
Bonnen, MD ;
Garden, AS ;
Myers, JN ;
Gershenwald, JE ;
Zagars, GK ;
Schechter, NR ;
Morrison, WH ;
Ross, MI ;
Ang, KK .
CANCER, 2003, 97 (07) :1789-1796
[6]   A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma [J].
Ballo, MT ;
Zagars, GK ;
Gershenwald, JE ;
Lee, JE ;
Mansfield, PF ;
Kim, KB ;
Camacho, LH ;
Hwu, P ;
Ross, MI .
ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (12) :1079-1084
[7]   Observation After a Positive Sentinel Lymph Node Biopsy in Patients with Melanoma [J].
Bamboat, Zubin M. ;
Konstantinidis, Ioannis T. ;
Kuk, Deborah ;
Ariyan, Charlotte E. ;
Brady, Mary Sue ;
Coit, Daniel G. .
ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (09) :3117-3123
[8]   Sentinel Lymph Node Biopsy in Melanoma [J].
Boland, Genevieve M. ;
Gershenwald, Jeffrey E. .
CANCER JOURNAL, 2012, 18 (02) :185-191
[9]   Systemic Therapies for Advanced Melanoma [J].
Bomar, Leonora ;
Senithilnathan, Aditi ;
Ahn, Christine .
DERMATOLOGIC CLINICS, 2019, 37 (04) :409-+
[10]   The amount of metastatic melanoma in a sentinel lymph node: Does it have prognostic significance? [J].
Carlson, GW ;
Murray, DR ;
Lyles, RH ;
Staley, CA ;
Hestley, A ;
Cohen, C .
ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (05) :575-581